We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
24 Feb 2021 - 28 Feb 2021
Virtual Venue
03 Mar 2021 - 05 Mar 2021
Virtual Venue

Researchers Develop World’s First AI-Augmented Ova and Parasite Detection Tool

By LabMedica International staff writers
Posted on 29 Aug 2019
Print article
Image: ARUP Laboratories and Techcyte have developed the world’s first AI-augmented ova and parasite detection tool (Photo courtesy of Techcyte).
Image: ARUP Laboratories and Techcyte have developed the world’s first AI-augmented ova and parasite detection tool (Photo courtesy of Techcyte).
ARUP Laboratories (Salt Lake City, UT, USA), a national reference laboratory engaged in innovative laboratory research and development, and Techcyte (Lindon, UT, USA), a developer of artificial intelligence (AI) based image analysis solutions for the diagnostics industry, have developed the world’s first AI-augmented ova and parasite detection tool.

ARUP, a national clinical and anatomic pathology reference laboratory, is a non-profit enterprise of the University of Utah and offers an extensive test menu of highly complex and unique medical tests. Techcyte, which was founded as a technology transfer from the University of Utah, uses the power of deep machine learning to perform image analysis of whole slide images. Techcyte’s digital diagnostics platform applies the latest in convolutional neural networks to pre-classify the fecal sample images captured by a 3DHISTECH Pannoramic 250-Flash III scanner. Pre-classifying the images using the Techcyte tool allows ARUP’s technologists to efficiently read stained glass slides manually and improves the accuracy of parasite detection.

For laboratorians, digitally enabling the workflow will decrease the physical demands of looking through a microscope for extended periods of time, including eye fatigue and neuromuscular tension. The technology can quickly screen out negative results, allowing laboratorians to spend more time analyzing positive slides. The ova and parasite tool is the first among several projects being co-developed by ARUP and Techcyte. ARUP’s medical expertise and access to samples, combined with Techcyte’s technical ability and digital evaluation platform, will produce high quality algorithms that can be developed and applied to future unmet laboratory needs.

“The collaboration with Techcyte has produced an AI-augmented detection tool that significantly advances our diagnostic capabilities in our parasitology lab,” said Adam Barker, PhD, director of Research and Development at ARUP. “This will allow for faster turnaround times, decreased costs, employee satisfaction and improved patient care.”

“Microscopy-based diagnostic parasitology has remained woefully static for decades. We have successfully developed a pioneering breakthrough with this tool, the likes of which had previously been unimaginable by classically trained microbiologists,” said Dr. Marc Couturier, medical director of ARUP’s Parasitology labs.

“This revolutionary partnership will combine ARUP’s vast expertise and reputation in the market with Techcyte’s AI-based image analysis capabilities to change the way lab diagnostics are performed,” said Ralph Yarro, CEO of Techcyte.

Related Links:
ARUP Laboratories
Techcyte


Print article

Channels

Molecular Diagnostics

view channel
Image: Blood smear from a P. falciparum culture: several red blood cells have ring stages inside them while close to the center is a schizont and on the left a trophozoite (Photo courtesy of Wikimedia Commons)

Panel of MicroRNAs Differentiates Uncomplicated and Severe Malaria in Children

MicroRNAs (miRNAs), which are rapidly released from damaged tissues into the host fluids, constitute a promising biomarker for the prognosis of severe malaria. MiRNAs comprise a class of about 20 n... Read more

Pathology

view channel
Image: The Leica Bond III stainer is fully automated Immunohistochemical and In Situ Hybridization (IHC and ISH stainer) (Photo courtesy of Leica Biosystems).

Mismatch Repair/Microsatellite Instability Evaluated Using Cytology Effusion Specimens

DNA mismatch repair (MMR) status is routinely assessed in colorectal and endometrial carcinoma as a method of cancer prevention, surveillance in patients with Lynch syndrome and their families, and for... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.